Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
10/2010
10/28/2010US20100273793 6-ARYL/HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS c-MET INHIBITORS
10/28/2010US20100273653 Use of Compounds Having a Mongalactosydiacylglycerol Syhnthase Inhibitory Activity as Herbicide or Algaecide, Herbicide and Algaecide Compositions
10/27/2010CN1809606B Conducting membrane generated from silane with functional group
10/27/2010CN101870691A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
10/27/2010CN101870681A Bis-phenanthroimidazolyl compound and electroluminescent device using the same
10/27/2010CN101052639B Benzimidazole derivatives, composition containing thereof, its preparation method and application
10/26/2010US7820664 N-(2-aylamino)aryl sulfonamides such as N-(7-(4-bromo-2-fluorophenylamino)imidazo[1,2-b]pyridazin-6-yl)-1-(2-hydroxyethyl)cyclopropane-1-sulfonamide; mitogen-activated ERK activating kinase (MEK) inhibitors; antiproliferative, anticarcinogenic, and antiinflammatory agents
10/21/2010WO2010120872A2 Method of decreasing pro-adam10 secretase and/or beta secretase levels
10/21/2010WO2010118670A1 Dichloropropene compounds and uses thereof
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267714 Mif modulators
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267676 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010US20100267004 Method, Substances and Kits for Labeling Population of RNA and Other Substances Containing Vicinal Diols
10/20/2010EP2240425A1 Novel materials for organic electroluminescent devices
10/20/2010EP2240019A1 Acid mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase
10/20/2010EP1968949B1 Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
10/20/2010EP1899299B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
10/20/2010CN101863851A Dichloropropylene compound and application thereof
10/20/2010CN101863841A Substituted tetracycline compounds
10/20/2010CN101863840A Preparation method of 5-amino-6-methyl benzimidazolone
10/20/2010CN101863839A N-3-aramid-5-cyclopropane spiro hydantoin derivative, preparation method and application thereof
10/20/2010CN101863838A Method for synthesizing benzodiamine spiro-ring drug template
10/19/2010US7816540 Carboxyl- or hydroxyl-substituted benzimidazole derivatives
10/19/2010US7816539 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/19/2010US7816536 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same
10/19/2010US7816388 Complexes with radionuclides; radiotherapy or diagnosis of tumors; e.g. two tetraazacyclododecanetetraacetic acid (DOTA) chelators conjugated to the side of biotin
10/19/2010CA2393158C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/14/2010WO2010117756A2 Substituted benzimidazole pharmaceutical formulations
10/14/2010WO2010117064A1 Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst
10/14/2010WO2010116380A2 A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
10/14/2010WO2010115736A2 Dihydroorotate dehydrogenase inhibitors
10/14/2010WO2010081670A3 Process for the preparation of benzimidazoles
10/14/2010US20100261909 Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
10/14/2010US20100261899 Imidazole compounds
10/14/2010US20100261898 Imidazole compounds
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261608 Geminal alkoxy/alkylspirocyclic substituted tetramate derivatives
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/13/2010EP2238117A1 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/13/2010EP1994011B1 Sulfonyl benzimidazole derivatives
10/13/2010EP1783129B1 Spiropiperidyl rifamycins for the treatment of microbacterial infections
10/13/2010CN101133036B Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
10/12/2010US7812042 novel synthetic thiolatocobalamin; protects animal cells against oxidative stress damage; dietary supplement; also with vitamin B6 and a folate; cardiovascular disease, cerebrovascular disease, peripheral vascular disease, glaucoma, Alzheimer's disease, and dementia
10/07/2010WO2010111948A1 Arylmethylamine compounds, preparation methods and pharmaceutical uses thereof
10/07/2010US20100256203 Benzimidazoles and pharmaceutical compositions thereof
10/07/2010US20100256188 New compounds
10/07/2010US20100256138 Benzimidazole derivatives: preparation and pharmaceutical applications
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/06/2010EP2236501A1 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same
10/06/2010EP2234984A1 Fluoroalkyl substituted benzimidazole cannabinoid agonists
10/06/2010EP2234983A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
10/06/2010CN101855214A Benzimidazole derivatives and their use as FXR agonists
10/06/2010CN101855206A N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
10/06/2010CN101851235A Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same
10/06/2010CN101851210A Terphenyl bridged-bis-benzimidazole quaternary ammonium compound, synthetic method and application thereof
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807842 Synthesis of tetracyclines and analogues thereof
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010CA2441331C Bicyclic guanidine derivatives and therapeutic uses thereof
10/05/2010CA2362930C Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
09/2010
09/30/2010WO2010111303A2 Imaging agents for detecting neurological disorders
09/30/2010WO2010110277A1 Organic electroluminescent element
09/30/2010WO2010108903A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010077852A3 Method of inducing cleavage of amyloid precursor protein to form a novel fragment
09/30/2010WO2010054330A3 Monofunctional carbocyanine dyes for in vivo and in vitro imaging
09/30/2010US20100249349 Novel Polymers
09/30/2010US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
09/30/2010US20100249143 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds
09/30/2010US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249091 Amide Compounds Useful in Therapy
09/30/2010US20100248313 Novel optically active, heteroaromatic beta-hydroxy esters and processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
09/30/2010US20100247583 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
09/30/2010CA2756137A1 Imaging agents for detecting neurological disorders
09/30/2010CA2754176A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/29/2010EP2231617A1 Benzimidazole compounds
09/29/2010EP1638928B1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides
09/29/2010CN201592005U Demister for Naphthol AS-BI alkaline water washing kettle
09/29/2010CN101848710A Anthelmintic combination
09/29/2010CN101845006A Beta-alkyl sulfide substituted vinyl propionate sulfur compound and preparation method thereof
09/29/2010CN101312233B Organic electroluminescent device and display apparatus
09/28/2010US7803967 1-amino-1carboxy-4-alkyl (1-4 carbons)cyclohexanes; chemical intermediates forinsecticides; miticides, pesticides, herbicides, and drugs; for preparing substituted phenylketoenols which can be used as pesticides and herbicides
09/28/2010US7803814 Tricyclic steroid hormone nuclear receptor modulators
09/23/2010US20100240715 Apoptosis promoters
09/23/2010US20100240702 Benzimidazolone Chymase Inhibitors
09/23/2010US20100240580 Azoloarine derivatives, method for the production thereof, pharmaceuticals containing these compounds and the use thereof
09/23/2010US20100239496 Imaging agents for detecting neurological disorders
09/22/2010EP2230233A1 1,3-dialkyl-benzimidazole halogenides exhibiting regeneration, anti-inflammatory and antimicrobial activity
09/22/2010EP2021330B1 Benzimidazole modulators of vr1
09/22/2010EP1692114B1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
09/22/2010CN101307023B Production process of 5-acetyl acetamino benzimidazolone
09/21/2010US7799929 Biotin intermediate and process for preparing the same
09/21/2010US7799927 optical recording media with said organic dye as recording layer; high density Disk-Recordable (HD DVD-R)
09/21/2010US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2428019C Estrogen receptor modulators
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/16/2010WO2010103283A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 154